Application 211510

Type
ANDA
Sponsor
TEVA PHARMS USA

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001LIOTHYRONINE SODIUMLIOTHYRONINE SODIUMTABLET;ORALEQ 0.005MG BASENoNo
002LIOTHYRONINE SODIUMLIOTHYRONINE SODIUMTABLET;ORALEQ 0.025MG BASENoNo
003LIOTHYRONINE SODIUMLIOTHYRONINE SODIUMTABLET;ORALEQ 0.05MG BASENoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
0093-2178Liothyronine SodiumLiothyronine SodiumTeva Pharmaceuticals USA, Inc.ANDACurrent
0093-2178Liothyronine SodiumLiothyronine SodiumTeva Pharmaceuticals USA, Inc.ANDACurrent
0093-2179Liothyronine SodiumLiothyronine SodiumTeva Pharmaceuticals USA, Inc.ANDACurrent
0093-2179Liothyronine SodiumLiothyronine SodiumTeva Pharmaceuticals USA, Inc.ANDACurrent
0093-2180Liothyronine SodiumLiothyronine SodiumTeva Pharmaceuticals USA, Inc.ANDACurrent
0093-2180Liothyronine SodiumLiothyronine SodiumTeva Pharmaceuticals USA, Inc.ANDACurrent